Abstract
Get full access to this article
View all access options for this article.
References
1.
van der Leest
P
,
Hiddinga
B
,
Miedema
A
,
Aguirre Azpurua
ML
,
Rifaela
N
,
Ter Elst
A
,
Timens
W
,
Groen
HJM
,
van Kempen
LC
,
Hiltermann
TJN
,
Schuuring
E
Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors. Mol Oncol . 2021 Nov ; 15 (11 ):2910 –2922 . doi: 10.1002/1878-0261.13090. Epub 2021 Sep 25 . Erratum in: Mol Oncol. 2022 Jan;16(1):310.